Cumberland Partners Ltd Increases Position in UnitedHealth Group Incorporated $UNH

Key Points

• Cumberland Partners Ltd increased its UnitedHealth Group stake by 22.6% in the fourth quarter, buying 12,034 shares and bringing its total to 65,256 shares valued at about $21.5 million.
• UnitedHealth recently beat quarterly earnings expectations, reporting $7.23 EPS versus the $6.76 consensus and revenue of $111.65 billion, with revenue up 2% year over year.
• Analyst sentiment remains positive, with several firms raising price targets and the stock carrying a Moderate Buy rating overall; the average target price is $387.57.

Cumberland Partners Ltd lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 22.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,256 shares of the healthcare conglomerate's stock after purchasing an additional 12,034 shares during the period. UnitedHealth Group comprises about 1.3% of Cumberland Partners Ltd's portfolio, making the stock its 22nd largest holding. Cumberland Partners Ltd's holdings in UnitedHealth Group were worth $21,542,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Guerra Advisors Inc purchased a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $1,059,000. Money Concepts Capital Corp grew its position in shares of UnitedHealth Group by 59.1% in the third quarter. Money Concepts Capital Corp now owns 12,380 shares of the healthcare conglomerate's stock valued at $4,275,000 after purchasing an additional 4,600 shares in the last quarter. Phoenix Financial Ltd. grew its position in shares of UnitedHealth Group by 111.5% in the third quarter. Phoenix Financial Ltd. now owns 41,986 shares of the healthcare conglomerate's stock valued at $14,282,000 after purchasing an additional 22,137 shares in the last quarter. Public Sector Pension Investment Board grew its position in shares of UnitedHealth Group by 43.1% in the third quarter. Public Sector Pension Investment Board now owns 287,132 shares of the healthcare conglomerate's stock valued at $99,147,000 after purchasing an additional 86,432 shares in the last quarter. Finally, Compass Wealth Management LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $13,691,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

UNH has been the subject of a number of analyst reports. Argus upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $400.00 price target for the company in a research report on Wednesday, April 22nd. Piper Sandler reiterated an "overweight" rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. Jefferies Financial Group upped their price objective on UnitedHealth Group from $340.00 to $373.00 and gave the company a "buy" rating in a report on Monday, April 20th. Raymond James Financial upgraded UnitedHealth Group from a "market perform" rating to an "outperform" rating and set a $330.00 price objective on the stock in a report on Wednesday, April 1st. Finally, Morgan Stanley upped their price objective on UnitedHealth Group from $375.00 to $395.00 and gave the company an "overweight" rating in a report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $387.57.

UnitedHealth Group Stock Up 1.6%

NYSE:UNH opened at $388.42 on Friday. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The stock's fifty day moving average is $326.93 and its two-hundred day moving average is $319.63. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $404.15. The stock has a market capitalization of $352.74 billion, a price-to-earnings ratio of 29.34, a price-to-earnings-growth ratio of 1.65 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping analysts' consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The company had revenue of $111.65 billion for the quarter, compared to analysts' expectations of $109.84 billion. During the same period in the prior year, the firm earned $7.20 earnings per share. The firm's revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 18.29 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date was Monday, March 9th. UnitedHealth Group's dividend payout ratio is 66.77%.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.28% of the company's stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UBS raised its price target on UnitedHealth Group to $460 from $410 and reiterated a Buy rating, signaling meaningful upside from current levels. Benzinga report on UBS target increase
• Positive Sentiment: UnitedHealth was highlighted by multiple outlets as a high-quality stock and a turnaround bet, with commentary noting that managed care is outgrowing the broader economy and that the company is benefiting from AI adoption in operations. Motley Fool article on AI and turnaround
• Neutral Sentiment: UnitedHealth also appeared in a hedge-fund “high quality stocks” list and a Goldman Sachs conviction-list discussion, which supports the stock’s investment case but does not change fundamentals on its own. InsiderMonkey article on turnaround case
• Negative Sentiment: There is still headline risk around Medicare Advantage overpayments, with a Congressional committee estimating about $7 billion annually in excess payments to private insurers, which could keep regulatory scrutiny on managed-care names like UNH. 247WallSt article on Medicare Advantage overpayments
• Negative Sentiment: Recent discussion also noted that Berkshire-linked selling contributed to a prior stock slide, underscoring that investor sentiment can still turn quickly. Barchart article on Berkshire stake sale

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.